1. Home
  2. MYPS vs ENTA Comparison

MYPS vs ENTA Comparison

Compare MYPS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.66

Market Cap

114.4M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.44

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYPS
ENTA
Founded
2011
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.4M
486.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
MYPS
ENTA
Price
$0.66
$14.44
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$2.00
$20.40
AVG Volume (30 Days)
195.5K
381.3K
Earning Date
11-03-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$247,477,000.00
$65,324,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
N/A
$0.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$4.09
52 Week High
$2.00
$17.15

Technical Indicators

Market Signals
Indicator
MYPS
ENTA
Relative Strength Index (RSI) 46.53 47.94
Support Level $0.64 $14.07
Resistance Level $0.70 $17.15
Average True Range (ATR) 0.03 1.03
MACD 0.01 -0.13
Stochastic Oscillator 38.99 14.69

Price Performance

Historical Comparison
MYPS
ENTA

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: